Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response
Open Access
- 25 April 2023
- journal article
- research article
- Published by Taylor & Francis in Gut Microbes
- Vol. 15 (1) , 2203963
Abstract
Prodrugs reliant on microbial activation are widely used but exhibit a range of efficacies that remain poorly understood. The anti-inflammatory compound 5-aminosalicylic acid (5-ASA), which is packaged in a variety of azo-linked prodrugs provided to most Ulcerative Colitis (UC) patients, shows confounding inter-individual variabilities in response. Such prodrugs must be activated by azo-bond reduction to form 5-ASA, a process that has been attributed to both enzymatic and non-enzymatic catalysis. Gut microbial azoreductases (AzoRs) are the first catalysts shown to activate azo-linked drugs and to metabolize toxic azo-chemicals. Here, we chart the scope of the structural and functional diversity of AzoRs in health and in patients with the inflammatory bowel diseases (IBDs) UC and Crohn’s Disease (CD). Using structural metagenomics, we define the landscape of gut microbial AzoRs in 413 healthy donor and 1059 IBD patient fecal samples. Firmicutes encode a significantly higher number of unique AzoRs compared to other phyla. However, structural and biochemical analyses of distinct AzoRs from the human microbiome reveal significant differences between prevalent orthologs in the processing of toxic azo-dyes, and their generally poor activation of IBD prodrugs. Furthermore, while individuals with IBD show higher abundances of AzoR-encoding gut microbial taxa than healthy controls, the overall abundance of AzoR-encoding microbes is markedly low in both disease and health. Together, these results establish that gut microbial AzoRs are functionally diverse but sparse in both health and disease, factors that may contribute to non-optimal processing of azo-linked prodrugs and idiopathic IBD drug responses.Keywords
All Related Versions
Funding Information
- National Institutes of Health (GM137286)
This publication has 68 references indexed in Scilit:
- Activation of nitrofurazone by azoreductases: multiple activities in one enzymeScientific Reports, 2011
- Interplay between NS3 protease and human La protein regulates translation-replication switch of Hepatitis C virusScientific Reports, 2011
- A Novel Mechanism for AzoreductionJournal of Molecular Biology, 2010
- Role of tyrosine 131 in the active site of paAzoR1, an azoreductase with specificity for the inflammatory bowel disease prodrug balsalazideActa Crystallographica Section F Structural Biology and Crystallization Communications, 2009
- BLAST+: architecture and applicationsBMC Bioinformatics, 2009
- Molecular Cloning, Characterisation and Ligand-bound Structure of an Azoreductase from Pseudomonas aeruginosaJournal of Molecular Biology, 2007
- Crystal structure of the flavoprotein ArsH from Sinorhizobium melilotiFEBS Letters, 2007
- Three-dimensional Structure of AzoR from Escherichia coliJournal of Biological Chemistry, 2006
- Expression and characteristics of the gene encoding azoreductase from Rhodobacter sphaeroides AS1.1737FEMS Microbiology Letters, 2004
- Reduction of azo dyes and nitroaromatic compounds by bacterial enzymes from the human intestinal tract.Environmental Health Perspectives, 1995